152 related articles for article (PubMed ID: 15636632)
1. Tacrolimus and pure red-cell aplasia.
Gregoor PS; Weimar W
Am J Transplant; 2005 Jan; 5(1):195-6. PubMed ID: 15636632
[No Abstract] [Full Text] [Related]
2. T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
Arcasoy MO; Chao NJ
Am J Hematol; 2005 Feb; 78(2):161-3. PubMed ID: 15682416
[No Abstract] [Full Text] [Related]
3. Treatment of pure red-cell aplasia with cyclosporine in a renal transplant patient.
Yildirim R; Bilen Y; Keles M; Uyanik A; Gokbulut P; Aydinli B
Exp Clin Transplant; 2013 Feb; 11(1):63-5. PubMed ID: 22891934
[TBL] [Abstract][Full Text] [Related]
4. Pure Red Cell Aplasia in a Renal Transplant Recipient: Case Report and Review of the Literature.
Nagib AM; Gheith OA; Zahab MA; Balaha MA; Elserwey NA; Sobhy I; Nair P; Al-Otaibi T
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):136-139. PubMed ID: 35384824
[TBL] [Abstract][Full Text] [Related]
5. Immunocompetence assay for net effect of combined immunosuppression.
Nagashima N; Shalabi A; Watanabe T; Ogawa N; Koyama I; Kyo S; Burdick JF
Transplant Proc; 2001 May; 33(3):2350-1. PubMed ID: 11377556
[No Abstract] [Full Text] [Related]
6. A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
Kitpermkiat R; Thotsiri S; Arpornsujaritkun N; Sangkum P; Chantrathammachart P; Kitpoka P; Thammanichanond D; Virankabutra T; Kantachuvesiri S
Am J Case Rep; 2022 Jul; 23():e935451. PubMed ID: 35842751
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine in the treatment of azathioprine-induced red cell aplasia following renal transplantation.
Vogt B; Fivush BA
Pediatr Nephrol; 1992 May; 6(3):278-9. PubMed ID: 1616841
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function.
Hohage H; Zeh M; Heck M; Gerhardt UW; Welling U; Suwelack BM
Transplant Proc; 2005 May; 37(4):1748-50. PubMed ID: 15919453
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus-Associated Pure Red Cell Aplasia in a Patient With Renal Transplant.
Yucel OK; Alemdar MS; Akkaya B; Kocak H; Suleymanlar G; Yilmaz VT
Exp Clin Transplant; 2022 Dec; 20(12):1131-1133. PubMed ID: 33272158
[TBL] [Abstract][Full Text] [Related]
10. Assessment of immunosuppression by lymphocyte functions in human blood.
Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
[No Abstract] [Full Text] [Related]
11. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
12. Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin.
Ilan Y; Naparstek Y
Acta Haematol; 1993; 89(3):152-4. PubMed ID: 8362604
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological efficacy of mycophenolic acid before and after renal transplantation as estimated by the lymphocyte immunosuppressant sensitivity test (LIST).
Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):430-6. PubMed ID: 20095807
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil pharmacokinetics in transplant patients receiving cyclosporine or tacrolimus in combination therapy.
Vidal E; Cantarell C; Capdevila L; Monforte V; Roman A; Pou L
Pharmacol Toxicol; 2000 Oct; 87(4):182-4. PubMed ID: 11097273
[TBL] [Abstract][Full Text] [Related]
15. Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?
Picard N
Clin Pharmacol Ther; 2010 Jun; 87(6):650-1. PubMed ID: 20393455
[No Abstract] [Full Text] [Related]
16. Immunopharmacology of new xenobiotic immunosuppressive molecules.
Morris RE
Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
[No Abstract] [Full Text] [Related]
17. Immunosuppressive agents: recent developments in molecular action and clinical application.
Gerber DA; Bonham CA; Thomson AW
Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
[No Abstract] [Full Text] [Related]
18. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase.
Mino Y; Naito T; Otsuka A; Takayama T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharm Ther; 2011 Apr; 36(2):217-24. PubMed ID: 21366651
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid.
Briggs WA; Eustace J; Gimenez LF; Choi MJ; Scheel PJ; Burdick JF
J Clin Pharmacol; 1999 Feb; 39(2):125-30. PubMed ID: 11563403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
